<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03118921</url>
  </required_header>
  <id_info>
    <org_study_id>REVAM</org_study_id>
    <nct_id>NCT03118921</nct_id>
  </id_info>
  <brief_title>Body Image Disorder in Anorexia Nervosa and Virtual Reality</brief_title>
  <acronym>REVAM</acronym>
  <official_title>Body Image Disorder in Anorexia Nervosa and Virtual Reality</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the tolerance and acceptability of the virtual representation of its body
      image.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 20, 2017</start_date>
  <completion_date type="Anticipated">May 3, 2018</completion_date>
  <primary_completion_date type="Anticipated">April 20, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Self-questionnaire assessing tolerance</measure>
    <time_frame>Day 15</time_frame>
    <description>Patients will have to respond to a self-administered questionnaire assessing tolerance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Self-questionnaire assessing acceptability</measure>
    <time_frame>Day 15</time_frame>
    <description>Patients will have to respond to a self-administered questionnaire assessing acceptability</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Feeling of presence</measure>
    <time_frame>Day 15</time_frame>
    <description>Patients will respond to a self-questionnaire of feeling of presence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective experience by EDI-2 questionnaire</measure>
    <time_frame>Day 15</time_frame>
    <description>Pre- and post-test comparison of body dissatisfaction by EDI-2 questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective experience by BSQ questionnaire</measure>
    <time_frame>Day 15</time_frame>
    <description>Pre- and post-test comparison of body dissatisfaction by BSQ questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Anorexia</condition>
  <arm_group>
    <arm_group_label>Virtual reality</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The first session aims to present the virtual reality material that will be used. The second session will take place 2 weeks after the first session and will consist of the use of the immersion software</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Virtual reality</intervention_name>
    <description>The first session aims to present the virtual reality material that will be used. The second session will take place 2 weeks after the first session and will consist of the use of the immersion software.</description>
    <arm_group_label>Virtual reality</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women, aged between 16 and 40

          -  Post-puberty

          -  Pure restrictive anorexia nervosa, diagnosis by the DSM-V

          -  BMI &lt;17.5

          -  Patient attending an outpatient clinic at the Bohars Psychiatric Hospital in France

          -  Having signed the Informed Consent Form

          -  For minor patients, signing the form of informed consent of both parents

        Exclusion Criteria:

          -  Associated eating disorder (bulimia, or the binge eating / purging form of anorexia
             nervosa),

          -  Psychiatric disorders (characterized depressed, anxiety disorder)

          -  Neurological Disorders

          -  Mental retardation

          -  Abuse or addiction to alcohol

          -  Abuse or dependence on psychoactive substances in the previous year.

          -  Patient with a protective justice measure
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sofian Berrouiguet, Doctor</last_name>
    <email>sofian.berrouiguet@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU Brest</name>
      <address>
        <city>Brest</city>
        <zip>29200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sofian Berrouiguet</last_name>
      <email>sofian.berrouiguet@chu-brest.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 3, 2017</study_first_submitted>
  <study_first_submitted_qc>April 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2017</study_first_posted>
  <last_update_submitted>July 10, 2017</last_update_submitted>
  <last_update_submitted_qc>July 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anorexia</mesh_term>
    <mesh_term>Anorexia Nervosa</mesh_term>
    <mesh_term>Body Dysmorphic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

